Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Maynds Tower Mental Clinic, Tokyo, Japan
Study leads
Nobuhito Sanada
Study Director
Otsuka Pharmaceutical Co., Ltd.